MediciNova
MNOV
#9504
Rank
ยฃ57.43 M
Marketcap
ยฃ1.17
Share price
0.65%
Change (1 day)
-33.89%
Change (1 year)

Operating Margin for MediciNova (MNOV)

Operating Margin as of December 2025 (TTM): -150.25%

According to MediciNova's latest financial reports and stock price the company's current Operating Margin is -150.25%. At the end of 2023 the company had an Operating Margin of -856.85%.

Operating Margin history for MediciNova from 2004 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2023-856.85%
2021-250.94%
2013-67.04%-95.09%
2012-1,364.37%
2006-15,794.30%322.09%
2005-3,741.93%-62.26%
2004-9,915.19%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Eli Lilly
LLY
37.87%-125.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-556,900.00% 370,548.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
15.12%-110.06%๐Ÿ‡ซ๐Ÿ‡ท France
Alkermes
ALKS
28.48%-118.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
-7.76%-94.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
29.12%-119.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.